These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

931 related items for PubMed ID: 12716249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
    Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ.
    Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clozapine for treatment-refractory mania.
    Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY.
    Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
    [Abstract] [Full Text] [Related]

  • 10. Clozapine treatment in a population of adults with mental retardation.
    Antonacci DJ, de Groot CM.
    J Clin Psychiatry; 2000 Jan; 61(1):22-5. PubMed ID: 10695641
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
    Díaz-Marsá M, Sánchez S, Rico-Villademoros F, ZIP-IIG-79 Study Group.
    J Clin Psychiatry; 2009 Apr; 70(4):509-17. PubMed ID: 19358789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
    Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K.
    J Clin Psychiatry; 2001 Apr; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.
    Hummel B, Dittmann S, Forsthoff A, Matzner N, Amann B, Grunze H.
    Neuropsychobiology; 2002 Apr; 45 Suppl 1():37-42. PubMed ID: 11893876
    [Abstract] [Full Text] [Related]

  • 17. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
    Stewart M, DelBello MP, Versavel M, Keller D.
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):635-40. PubMed ID: 20035581
    [Abstract] [Full Text] [Related]

  • 18. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine.
    Pillay SS, Stoll AL, Weiss MK, Tohen M, Zarate CA, Banov MD, Cole JO.
    Ann Clin Psychiatry; 1996 Mar; 8(1):1-5. PubMed ID: 8743641
    [Abstract] [Full Text] [Related]

  • 19. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.